RecruitingNot ApplicableNCT06059521
Software Refraction With Mobilerone Versus Retinoscopy
Randomized Controlled Study on Subjective Refraction by Software Eye Test Technology Versus Retinoscopy
Sponsor
Beijing Airdoc Technology Co., Ltd.
Enrollment
120 participants
Start Date
Jul 15, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
Software refraction in the mobilerone for myopia and astigmatism is a novel medical device for myopia adults and elder children with or without astigmatism. And the investigators would like to test its accuracy and efficacy as well as safety.
Eligibility
Min Age: 10 YearsMax Age: 46 Years
Inclusion Criteria10
- • subject with ametropia on each eye ≤-12.00D
- subject with best corrected visual acuity ≥ 20/25, no amblyopia
- subject with normal transparency of eyes
- subject with a healthy fundus that does not reveal major abnormalities that may affect vision due to the fluctuate situations
- subject able to cooperate with the screen and the operator
- subject without heavy drug treatment that may affect vision as synthetic antimalarials, corticosteroids
- non-diabetic subject
- non nystagmus subject
- non-strabismus subject
- subject who has not had eye surgery less than 1 year old
Exclusion Criteria4
- • subject with a topography showing an anomaly (keratoconus type or other)
- subject with hyperopia or presbyopia
- subject with mild myopia ≥ -1.00D
- subject who cannot speak with the operator including those staff of local optometrists or ophthalmologists
Interventions
DEVICESoftware refraction with Eye Test Technology in a mobilerone
Refraction is done by software App by a mobilerone software installed.
DEVICERetinoscopy
Retinoscopy is an objective refraction method with retinoscope.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06059521